Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8070733 | 0.75 | CHRNB2 (0.46) | CHRNB2CHRNA4 | |
| SCHEMBL8484697 | 0.70 | CHRNB2 (0.39) | CHRNB2CHRNA4 | |
| SCHEMBL27585149 | 0.64 | CHRNB2 (0.41) | CHRNB2CHRNA4 | |
| SCHEMBL31014511 | 0.63 | CYP11B2 (0.46) | CHRNB2CHRNA4 | |
| SCHEMBL29845299 | 0.62 | POLB (0.38) | CHRNB2CHRNA4 | |
| SCHEMBL1426303 | 0.62 | POLB (0.38) | CHRNB2CHRNA4 | |
| SCHEMBL30116774 | 0.62 | CHRNA7 (0.46) | CHRNB2CHRNA4 | |
| SCHEMBL8076992 | 0.62 | CHRNA7 (0.46) | CHRNB2CHRNA4 | |
| SCHEMBL3058809 | 0.62 | CHRNB2 (0.62) | CHRNB2CHRNA4 | |
| SCHEMBL3058805 | 0.62 | CHRNB2 (0.62) | CHRNB2CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6100269-A | ADMINISTERING TO PATIENT NICOTINIC RECEPTOR AGONISTIC DERIVATIVES OF 3-(PYRIDYL OR PYRIMIDYL)-2-AZABICYCLO(2.2.1) HEPTANE OR 2-AZABICYCLO(2.2.2.)OCTANE TO ELICIT NEUROTRANSMITTER SECRETION WITH REDUCED SIDE EFFECTS | BENCHERIF MEROUANE (US) | 2000-08-08 | — | — | US | disclosed |
| US-5583140-A | ADMINISTERING 2-AZABICYCLO(2.2.2)OCT-5-ENE DERIVATIVES TO TREAT NEURODEGENERATIVE DISORDERS SUCH AS SENILE DEMENTIA OF ALZHEIMER'S TYPE | TARGACEPT, INC. A CORP. OF DE, | 1996-12-10 | — | — | US | disclosed |
| WO-1996036637-A1 | PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | R.J. REYNOLDS TOBACCO COMPANY (US) | 1996-11-21 | — | — | WO | disclosed |